neoplasms

Showing 1 - 25 of 928

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Tumors Trial in Strasbourg (Advance Care Planning Intervention)

Not yet recruiting
  • Neoplasms
  • Advance Care Planning Intervention
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Nov 20, 2023

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

Recruiting
  • Adenocarcinoma
  • +2 more
  • collection of biological samples
  • Bordeaux, France
  • +7 more
Nov 20, 2023

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

Breast Cancer, Breast Tumors, Breast Cancer Female Trial in United States (contrast-enhanced mammography)

Recruiting
  • Breast Cancer
  • +3 more
  • contrast-enhanced mammography
  • Bethel Park, Pennsylvania
  • +4 more
Oct 23, 2023

Tumors Trial in Chengdu

Recruiting
  • Neoplasms
    • Chengdu, Sichuan, China
      Departments of Nuclear Medicine, Sichuan Provincial People's Hos
    Oct 16, 2023

    Tumors Trial in United States (GSK4524101, Niraparib)

    Not yet recruiting
    • Neoplasms
    • San Francisco, California
    • +5 more
    Oct 5, 2023

    Tumors Trial in Nice (Self-questionnaire)

    Recruiting
    • Neoplasms
    • Self-questionnaire
    • Nice, France
      Centre Antoine lacassagne
    Sep 21, 2023

    Tumors Trial in Singapore (ENABLE-SG model, Wait-list control)

    Not yet recruiting
    • Neoplasms
    • ENABLE-SG model
    • Wait-list control
    • Singapore, Singapore
      National Cancer Centre Singapore
    Sep 12, 2023

    Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

    Terminated
    • Neoplasms
    • New Haven, Connecticut
    • +20 more
    Sep 15, 2023

    Tumors, Advance Care Planning Trial (Culturally Tailored Digital Resilience-Building)

    Not yet recruiting
    • Neoplasms
    • Advance Care Planning
    • Culturally Tailored Digital Resilience-Building
    • (no location specified)
    Sep 6, 2023

    Tumors, Prostate Cancer, Exercise Trial in Tucson (Exercising together)

    Not yet recruiting
    • Neoplasms
    • +3 more
    • Exercising together
    • Tucson, Arizona
      University of Arizona Cancer Center
    Aug 30, 2023

    Tumors, Cancer, Mental Health Disorder Trial in Taipei (Forest Therapy)

    Completed
    • Neoplasms
    • +3 more
    • Forest Therapy
    • Taipei, Taiwan
      Taipei city hospital
    Aug 19, 2023

    Noninvasive Internal Jugular Venous Oximetry

    Recruiting
    • Neoplasms
      • Taipei, Taiwan
        National Taiwan University Hospital
      Aug 17, 2023

      Cardiotoxicity, Tumors, Chemo Effect Trial in São Paulo (Spironolactone, Placebo)

      Not yet recruiting
      • Cardiotoxicity
      • +3 more
      • São Paulo, Brazil
        Instituto do Coração
      Aug 16, 2023

      Lung Cancer, Multiple Pulmonary Nodules, Lung Tumors Trial in Orlando, Rochester, Pinehurst (Ion Endoluminal System)

      Not yet recruiting
      • Lung Cancer
      • +8 more
      • Ion Endoluminal System
      • Orlando, Florida
      • +2 more
      Aug 16, 2023

      Tumors, Lung Cancer, Physical Inactivity Trial in Hong Kong (Regular message delivery, Chat-type support message delivery)

      Not yet recruiting
      • Neoplasms
      • +3 more
      • Regular message delivery
      • Chat-type support message delivery
      • Hong Kong, Hong Kong
        School of Nursing, The University of Hong Kong
      Aug 15, 2023

      Tumors, Child, Adolescent Trial in Leiden (Ramucirumab, Cyclophosphamide, Vinorelbine)

      Recruiting
      • Neoplasms
      • +2 more
      • Leiden, Netherlands
        Leids Universitair Medisch Centrum
      Aug 14, 2023

      Tumors Trial in Worldwide (Letetresgene autoleucel)

      Active, not recruiting
      • Neoplasms
      • Letetresgene autoleucel
      • Pittsburgh, Pennsylvania
      • +5 more
      Aug 7, 2023

      Tumors Trial (Nordic Walking, Aquatic Exercise, Functional Exercise Training)

      Not yet recruiting
      • Neoplasms
      • Nordic Walking
      • +2 more
      • (no location specified)
      Jul 28, 2023

      Pancreas Tumor, Stomach Tumor, Gastrointestinal Tumors Trial (EO-3021)

      Not yet recruiting
      • Pancreas Neoplasm
      • +5 more
      • (no location specified)
      Jul 31, 2023

      Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

      Not yet recruiting
      • Neoplasms
      • +2 more
      • Nivolumab Injection [Opdivo]
      • (no location specified)
      Jul 19, 2023

      Tumors Trial in Hong Kong (A nurse-led symptom distress screening program)

      Not yet recruiting
      • Neoplasms
      • A nurse-led symptom distress screening program
      • Hong Kong, Hong Kong
      • +9 more
      Jul 17, 2023

      Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules

      Recruiting
      • Neoplasms
      • +13 more
      • HTL0039732 Capsules
      • HTL0039732 Capsules and atezolizumab infusion
      • Cambridge, United Kingdom
      • +4 more
      Jul 5, 2023

      Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

      Terminated
      • Neoplasms
      • New Haven, Connecticut
      • +20 more
      Jul 5, 2023